Lesion Pattern, Mechanisms, and Long-Term Prognosis in Patients with Monoparetic Stroke: A Comparison with Nonmonoparetic Stroke

Table 1

Comparison of clinical features between monoparetic and nonmonoparetic stroke patients at admission: number (%), mean ± SD.

	Nonmonoparetic stroke; = 555	Monoparetic stroke; = 31
Age	67.5 ± 13.7	68.8 ± 11.8	0.611
Female	260 (46.8)	13 (41.9)	0.594
Hypertension	371 (66.8)	23 (74.2)	0.396
Diabetes	164 (29.5)	12 (38.7)	0.279
Hyperlipidemia	287 (51.7)	21 (67.7)	0.082
Current smoking	150 (27.0)	8 (25.8)	0.882
Previous stroke	85 (15.3)	2 (6.5)	0.177
Ischemic heart disease	115 (20.7)	10 (32.3)	0.127
Atrial fibrillation	192 (34.6)	9 (29.0)	0.525
Valvular heat disease	113 (20.4)	5 (16.1)	0.568
Alcohol	92 (16.6)	3 (9.7)	0.310
Previous medication
Antiplatelet	221 (39.8)	15 (48.4)	0.344
Anticoagulant	80 (14.4)	6 (19.4)	0.449
Statin	145 (26.1)	16 (51.6)	0.002
Stenosis	286 (51.5)	14 (45.2)	0.490
Stenosis pattern			0.620
Intracranial and extracranial	82 (14.8)	3 (9.7)
Intracranial only	157 (28.3)	7 (22.6)
Extracranial only	47 (8.5)	4 (12.9)
No stenosis	269 (48.5)	17 (54.8)
TOAST classification			0.505
Large artery atherosclerosis	128 (23.1)	9 (29.0)
Lacune	85 (15.3)	3 (9.7)
Cardioembolism	207 (37.3)	12 (38.7)
Two or more	92 (16.6)	3 (9.7)
Cryptogenic	35 (6.3)	4 (12.9)
Other causes	8 (1.4)	0 (0)
Nonlacunar	470 (84.7)	28 (90.3)	0.392
Initial NIHSS	6.6 ± 7.9	1.3 ± 1.0	<0.001
Poor outcome	191 (34.4)	2 (6.5)	0.001

NIHSS: the National Institutes of Health Stroke Scale. Poor outcomes indicate modified Rankin scale ≥3 at 3 months.